← 產業報告目錄
Neuroplasticity Market Size, Share & Trends Analysis Report By Product Type (Software-Based Solutions, Hardware-Based Solutions), By Application (Stroke Rehabilitation, Traumatic Brain Injury (TBI) Rehabilitation, Neurodegenerative Disorders, Learning and Memory Enhancement, Mental Health Disorders), By End User, Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-16頁數 180報告編號 INSIGHTACE-9c4e68684f
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Neuroplasticity Market on a global scale was estimated at USD 7.9 billion in 2024 and is forecasted to attain USD 79.2 billion by 2034, with a projected CAGR of 26.0% between 2025 and 2034.
Neuroplasticity covers The capacity of the brain to reorganize itself by creating new neural connections as we age is known as neuroplasticity. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is fueled by surging appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neuroplasticity Market Snapshot
Chapter 4. Global Neuroplasticity Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
5.2.1. Software-Based Solutions
5.2.2. Hardware-Based Solutions
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Stroke Rehabilitation
6.2.2. Traumatic Brain Injury (TBI) Rehabilitation
6.2.3. Neurodegenerative Disorders
6.2.4. Learning and Memory Enhancement
6.2.5. Mental Health Disorders
Chapter 7. Market Segmentation 3: By End-user Estimates & Trend Analysis
7.1. By End-user & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:
7.2.1. Hospitals and Clinics
7.2.2. Research Institutes and Academic Centers
7.2.3. Pharmaceutical and Biotechnology Companies
7.2.4. Others
Chapter 8. Neuroplasticity Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
8.1.2. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
8.1.4. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Neuroplasticity Market revenue (US$ Million) By Product Type, 2021-2034
8.2.2. Europe Neuroplasticity Market revenue (US$ Million) By Application, 2021-2034
8.2.3. Europe Neuroplasticity Market revenue (US$ Million) By End-user, 2021-2034
8.2.4. Europe Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Product Type, 2021-2034
8.3.2. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Application, 2021-2034
8.3.3. Asia Pacific Neuroplasticity Market revenue (US$ Million) By End-user, 2021-2034
8.3.4. Asia Pacific Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.4.2. Latin America Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.3. Latin America Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
8.4.4. Latin America Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. NeuroSky Inc
9.2.2. Posit Science Corporation
9.2.3. BrainHQ
9.2.4. Synaptitude Brain Health
9.2.5. Mindmaze SA
9.2.6. NeuroVigil Inc
9.2.7. Lumosity
9.2.8. Neuronetics, Inc.
9.2.9. CogniFit, BrainHQ
9.2.10. Advanced Brain Monitoring
9.2.11. SharpBrains
9.2.12. Emotiv Inc
9.2.13. BrainCo
9.2.14. BrainHQ
9.2.15. Neuroscape
9.2.16. Neuroplast BV
9.2.17. Reha Technology AG
9.2.18. Virtualware Group
9.2.19. Nexeon Medsystems Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們